Lost Money on Hims & Hers Health, Inc.(HIMS)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

Core Viewpoint - Hims & Hers Health, Inc. is facing allegations of deceptive practices related to the promotion and sale of illegitimate versions of Wegovy®, which may jeopardize its collaboration with Novo Nordisk and mislead investors about the company's prospects [2]. Group 1: Allegations and Legal Action - The class period for the allegations is from April 29, 2025, to June 23, 2025 [2]. - Allegations include that Hims engaged in deceptive promotion and selling of illegitimate versions of Wegovy®, risking patient safety [2]. - The complaint suggests that the misleading statements from the company could lead to the termination of its collaboration with Novo Nordisk [2]. Group 2: Shareholder Information - Shareholders who purchased shares during the class period are encouraged to register for potential lead plaintiff appointment by August 25, 2025 [3]. - Registration allows shareholders to receive updates through a portfolio monitoring software regarding the case's status [3]. - There is no cost or obligation for shareholders to participate in the case [3]. Group 3: Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights against deceit and illegal business practices [4]. - The firm is dedicated to ensuring companies adhere to responsible business practices and good corporate citizenship [4]. - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated the company's stock [4].